Weekender 6/5/15

To Our New Jersey Life Sciences Community: Welcome to another edition of the Weekender. New Jersey Companies Continue Progress in Drug Development Edge Therapeutics, a BioNJ Member located in Berkeley Heights, announced that the U.S. Food and Drug Administration has granted orphan drug designation to EG-1962, the Company’s lead product candidate, which is in clinical… Read the full article


Weekender 5/29/15

To Our New Jersey Life Sciences Community: Welcome to another edition of the Weekender. Congratulations to four New Jersey companies that received Food and Drug Administration (FDA) approvals. These wonderful accomplishments shine a positive light on the dynamic life sciences ecosystem in New Jersey. We can’t wait to share more of your positive news throughout… Read the full article


Weekender 5/22/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Federal Research Bill Holds Promise for ‘Personalized Medicine’ in New Jersey The House Energy and Commerce Committee unanimously approved the 21st Century Cures Act, 51-0. The legislation has earned rave reviews across New Jersey’s research community, as well as its biotechnology and… Read the full article


Weekender 5/15/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. It’s Been a Banner Week for the New Jersey Life Sciences Community At the State level, Biosimilars legislation (A2477) was approved by the Assembly in a unanimous vote (72-0). This legislation allows pharmacists to substitute biosimilar products as long as the… Read the full article


Weekender 5/8/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Eli Lilly Receives Fourth FDA Approval For CYRAMZA Eli Lilly and Company received its fourth U.S. Food and Drug Administration (FDA) approval for CYRAMZA (ramucirumab), now also indicated in combination with FOLFIRI (irinotecan, folinic acid and 5-fluorouracil) chemotherapy for the treatment… Read the full article


Weekender 5/1/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. A Pair of FDA Approvals for New Jersey: The Medicines Company announced that they have received FDA approval for IONSYS (fentanyl iontophoretic transdermal system), the first needle-free, patient-controlled, pre-programmed fentanyl delivery system, for the short-term management of acute post-operative pain in adult patients requiring… Read the full article


Weekender 4/24/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Big News for BioNJ Member Advaxis: Advaxis was recently awarded two Vaccine Industry Excellence (ViE) Awards. The company finished first in “Best Financing Deal” and “Best Early-Stage Biotech;” and was Highly Commended in the “Best Biotech CEO” category. Congrats! Three BioNJ… Read the full article


Weekender 4/17/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. The Biotechnology Industry Organization (BIO) announced its selection of Representative Leonard Lance as Legislator of the Year for 2015. BioNJ was proud to nominate the Congressman for this honor, which is so well deserved given his leadership on so many fronts… Read the full article


Weekender 4/10/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. On April 22, BioNJ, BDO, NJEDA, and Tax Transfer Corporation will hold an educational Webinar entitled Don’t Leave Money on the Table! that will provide up-to-date information on important NOL Program changes. The Webinar starts at 10 a.m. and will feature BioNJ President… Read the full article


Weekender 4/3/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. The biotech industry opens the NASDAQ! BioNJ’s President and CEO Debbie Hart joined other biotech colleagues, including Jim Greenwood, President and CEO of BIO; Nathan Tinker, Executive Director of NewYorkBIO and Chris Molineaux, President of Pennsylvania BIO, to officially open trading… Read the full article